Pro Medicus Limited Stock
Stocks
PME
AU000000PME8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:07 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 166.87 AUD | +0.22% |
|
-3.22% | -24.45% |
| 08-20 | Pro Medicus' Unit Signs AU$25 Million Contract With US Health System | MT |
| 08-18 | Australia shares end flat as BHP, CSL offset banks' decline | RE |
| Market Cap | 17.43B 12.47B 10.75B 10.14B 9.23B 17.25B 1,191B 121B 46.49B 607B 46.87B 45.85B 1,926B | P/E 2027 * |
93.1x | P/E 2028 * | 72.9x |
|---|---|---|---|---|---|
| Enterprise Value | 17.14B 12.26B 10.57B 9.97B 9.07B 16.96B 1,171B 119B 45.71B 597B 46.08B 45.08B 1,893B | EV / Sales 2027 * |
50.6x | EV / Sales 2028 * | 40.6x |
| Free-Float |
51.04% | Yield 2027 * |
0.57% | Yield 2028 * | 0.68% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PME | Delayed | |
Tradegate
| PMC | Real-time | |
|
Boerse Muenchen
| PMC | Real-time | |
|
OTC Markets
| PMCUF | Delayed | |
|
Deutsche Boerse AG
| PMC | Delayed |
Last Transcript : Pro Medicus Limited
| 1 day | +0.22% | ||
| 1 week | -3.22% | ||
| Current month | -6.98% | ||
| 1 month | -5.23% | ||
| 3 months | +0.65% | ||
| 6 months | +26.90% | ||
| Current year | -24.45% |
| 1 week | 162.75 |  | 177.77 |
| 1 month | 162.75 | | 209.39 |
| Current year | 107.75 | | 223.02 |
| 1 year | 107.75 | | 321.57 |
| 3 years | 70.67 | | 336 |
| 5 years | 36.54 | | 336 |
| 10 years | 4.27 | | 336 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 2010-09-30 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 2026-03-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 1982-12-31 |
Peter Kempen
CHM | Chairman | 75 | 2010-07-31 |
Anthony Glenning
BRD | Director/Board Member | - | 2016-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/25/26 | Buy | Founder | 8,146 | 0.0078% | ||
| 2/25/26 | Buy | Founder | 9,000 | 0.0086% | ||
| 2/24/26 | Buy | Founder | 8,500 | 0.0081% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -3.22% | -44.06% | +129.00% | 12.54B | |
| +0.07% | -7.03% | -7.68% | +18.46% | 42.23B | |
| +0.70% | +0.14% | -12.29% | +74.67% | 5.71B | |
| -2.53% | -9.02% | +31.10% | - | 4.06B | |
| -0.84% | -5.47% | - | - | 1.99B | |
| -4.13% | -7.09% | -1.59% | -39.91% | 1.53B | |
| -2.40% | -5.63% | -36.51% | - | 1.06B | |
| -0.97% | +0.39% | +18.24% | +143.81% | 1.02B | |
| -2.29% | -9.23% | +34.25% | +43.46% | 923M | |
| -0.58% | -3.63% | -31.68% | -48.43% | 801M | |
| Average | -1.27% | -3.26% | -5.58% | +45.86% | 7.19B | |
| Weighted average by Cap. | -0.19% | -5.48% | -11.98% | +44.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 339M 242M 209M 197M 179M 335M 23.14B 2.35B 903M 11.79B 911M 891M 37.41B | 420M 300M 259M 244M 222M 415M 28.69B 2.91B 1.12B 14.62B 1.13B 1.1B 46.38B |
| Net income | 186M 133M 114M 108M 98.27M 184M 12.69B 1.29B 495M 6.46B 499M 488M 20.51B | 239M 171M 147M 139M 126M 236M 16.32B 1.65B 637M 8.31B 642M 628M 26.38B |
| Net Debt | -293M -210M -181M -171M -155M -290M -20.04B -2.03B -782M -10.21B -788M -771M -32.39B | -405M -290M -250M -236M -214M -401M -27.68B -2.81B -1.08B -14.1B -1.09B -1.07B -44.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | A$166.87 | +0.22% | 193,944 |
| 26-09-09 | A$166.51 | -1.82% | 187,831 |
| 26-09-08 | A$169.59 | +0.58% | 129,927 |
| 26-09-07 | A$168.61 | -3.07% | 106,580 |
| 26-09-04 | A$173.95 | +0.72% | 249,448 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PME Stock
Select your edition
All financial news and data tailored to specific country editions
